HORACE ELLIS: Open Payments
NPI 1457328734 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 10 payments from 5 companies in 2025. Trend: 2023 $396 · 2024 $26 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $98 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: INGREZZA, ABILIFY MAINTENA, Auvelity, COBENFY, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
